Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2013. CEO Chris Viehbacher comments on Q2 results and outlook.
Watch the video interview here:
Topics covered in the interview include:- Q2 2013 Results - FY 2013 Guidance - Capital Allocation - Diabetes - Vaccines - Genzyme - Animal Health - Emerging Markets - R&D Pipeline - Recent appointments About Sanofi Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Company website: www.sanofi.com